Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnet Study
2024-516559-41-00Phase 3Completed
- Sponsor
- TRICALS
- Start
- Nov 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Lithium with Placebo (2 arms). Primary endpoint: Overall survival. Started Nov 2024; status: completed.
02
Drugs
lithium
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2024-516559-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516559-41-00.